Cell communication and receptors

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/6

encourage image

There's no tags or description

Looks like no tags are added yet.

7 Terms

1
New cards

Compare the four main modes of intercellular signalling by mechanism, range, and speed.

  1. Contact-dependent: a membrane-bound signal molecule on one cell binds directly to a receptor on an adjacent target cell (short-range). 2. Paracrine: signalling cell releases local mediators that act on nearby target cells (short-range). 3. Synaptic: neurons fire action potentials along axons to release neurotransmitters across a synapse onto specific target cells (long-range, very fast). 4. Endocrine: endocrine cells secrete hormones into the bloodstream to reach distant target cells bearing specific receptors (long-range, slow).


2
New cards

Contrast cell-surface receptors with intracellular receptors in terms of ligand chemistry, mechanism, and response speed.

Cell-surface receptors bind hydrophilic signal molecules (e.g., histamine, insulin, adrenaline) that cannot cross the plasma membrane; they trigger intracellular signalling cascades producing either fast responses (less than seconds to minutes, altering existing protein function) or slow responses (minutes to hours, altering gene transcription and protein synthesis). Intracellular receptors bind small hydrophobic signal molecules (e.g., testosterone, thyroid hormone, oestrogen) carried in blood by carrier proteins that diffuse across the membrane to regulate gene promoters directly (slow response).

3
New cards

Explain how protein kinases and protein phosphatases act as molecular switches in intracellular signalling.

Protein kinases transfer a phosphate group from ATP onto hydroxyl (-OH) groups of serine (Ser), threonine (Thr), or tyrosine (Tyr) residues on target proteins, while protein phosphatases remove inorganic phosphate (Pi). Reversible phosphorylation alters protein conformation to increase or decrease enzymatic activity, create new protein-binding sites, or target proteins for degradation.

4
New cards

Illustrate how a single signalling molecule produces diverse physiological responses across different tissues, using acetylcholine and adrenaline.

Tissue-specific receptor subtypes and intracellular machinery dictate the response: Acetylcholine decreases contraction rate/force in heart muscle (via Gi-coupled M2 muscarinic receptors), stimulates secretion in salivary glands, and triggers contraction in skeletal and smooth muscle. Adrenaline stimulates heart rate/force (via β1 receptors, blocked by the antagonist propranolol) and relaxes bronchial smooth muscle (via β2 receptors, mimicked by the agonist salbutamol).

5
New cards

Describe the structure and activation cycle of G protein-coupled receptors (GPCRs).

Humans express ~800 GPCRs (~450 sensory for light/taste/smell; ~350 non-sensory drug targets), structured as seven-transmembrane (7TM) proteins with an extracellular N-terminus, transmembrane/extracellular ligand-binding sites, and an intracellular C-terminal G-protein coupling domain. Inactive state: heterotrimeric G protein (α, β, γ) binds GDP. Ligand binding activates the GPCR, triggering GDP-to-GTP exchange on the Gα subunit and dissociation of active Gα-GTP and the Gβγ dimer to modulate downstream effectors.

6
New cards

Compare the downstream signalling pathways of Gs, Gi, and Gq heterotrimeric G proteins and explain signal amplification.

  1. Gs (α): activates adenylyl cyclase (AC), converting ATP to cAMP (2nd messenger), which activates Protein Kinase A (PKA) to phosphorylate target proteins (e.g., adrenaline cascade amplifying 1 molecule to 10^8 glucose-1-phosphate molecules during glycogenolysis). 2. Gi (α): inhibits adenylyl cyclase, decreasing cAMP and PKA; Gi (βγ) directly opens K+ channels (e.g., acetylcholine hyperpolarizing heart muscle cells to slow heart rate). 3. Gq (α): activates phospholipase Cβ (PLCβ), generating IP3 (releases intracellular Ca2+) and DAG, which together activate Protein Kinase C (PKC).
7
New cards

List four clinical drugs that target GPCRs, naming their receptor, pharmacological action, and therapeutic use.

  1. Propranolol: antagonist (blocker) at Gs-coupled β-adrenergic receptors; blocks adrenaline's cardiac stimulation (used for hypertension and panic attacks). 2. Salbutamol: agonist at Gs-coupled β2-adrenergic receptors; mimics adrenaline to relax bronchial smooth muscle (used in asthma). 3. Atropine: antagonist at muscarinic acetylcholine receptors (mAChR); blocks vagal slowing of the heart, dilates pupils, and inhibits secretions. 4. Cimetidine: competitive antagonist at Gs-coupled histamine H2 receptors; blocks gastric acid secretion in the stomach.